76282-421-30 |
76282-421 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
30 mg/1 |
30 TABLET in 1 BOTTLE (76282-421-30) |
76282-421-45 |
76282-421 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
30 mg/1 |
45 TABLET in 1 BOTTLE (76282-421-45) |
76282-421-01 |
76282-421 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
30 mg/1 |
100 TABLET in 1 BOTTLE (76282-421-01) |
76282-421-05 |
76282-421 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
30 mg/1 |
500 TABLET in 1 BOTTLE (76282-421-05) |
76282-421-90 |
76282-421 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
30 mg/1 |
90 TABLET in 1 BOTTLE (76282-421-90) |
43353-009-60 |
43353-009 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20150316 |
N/A |
ANDA |
ANDA203508 |
Aphena Pharma Solutions - Tennessee, LLC |
LISINOPRIL |
40 mg/1 |
90 TABLET in 1 BOTTLE (43353-009-60) |
43353-009-80 |
43353-009 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20190718 |
N/A |
ANDA |
ANDA203508 |
Aphena Pharma Solutions - Tennessee, LLC |
LISINOPRIL |
40 mg/1 |
180 TABLET in 1 BOTTLE (43353-009-80) |
76282-418-90 |
76282-418 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
5 mg/1 |
90 TABLET in 1 BOTTLE (76282-418-90) |
76282-422-01 |
76282-422 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
40 mg/1 |
100 TABLET in 1 BOTTLE (76282-422-01) |
43353-301-30 |
43353-301 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170404 |
N/A |
ANDA |
ANDA203508 |
Aphena Pharma Solutions - Tennessee, LLC |
LISINOPRIL |
10 mg/1 |
30 TABLET in 1 BOTTLE (43353-301-30) |
43353-301-45 |
43353-301 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20210309 |
N/A |
ANDA |
ANDA203508 |
Aphena Pharma Solutions - Tennessee, LLC |
LISINOPRIL |
10 mg/1 |
45 TABLET in 1 BOTTLE (43353-301-45) |
43353-301-60 |
43353-301 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20210212 |
N/A |
ANDA |
ANDA203508 |
Aphena Pharma Solutions - Tennessee, LLC |
LISINOPRIL |
10 mg/1 |
90 TABLET in 1 BOTTLE (43353-301-60) |
76282-422-05 |
76282-422 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
40 mg/1 |
500 TABLET in 1 BOTTLE (76282-422-05) |
76282-422-10 |
76282-422 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
40 mg/1 |
1000 TABLET in 1 BOTTLE (76282-422-10) |
76282-422-18 |
76282-422 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
40 mg/1 |
180 TABLET in 1 BOTTLE (76282-422-18) |
76282-422-30 |
76282-422 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
40 mg/1 |
30 TABLET in 1 BOTTLE (76282-422-30) |
76282-422-45 |
76282-422 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
40 mg/1 |
45 TABLET in 1 BOTTLE (76282-422-45) |
76282-422-90 |
76282-422 |
HUMAN PRESCRIPTION DRUG |
lisinopril |
lisinopril |
TABLET |
ORAL |
20170322 |
N/A |
ANDA |
ANDA203508 |
Exelan Pharmaceuticals Inc. |
LISINOPRIL |
40 mg/1 |
90 TABLET in 1 BOTTLE (76282-422-90) |